Journal of Traditional Medical Complementary Therapies

.: ORIGINAL RESEARCH
The Effect of Wet Cupping Therapy on Anxiety and Thiol/Disulfide Homeostasis in Premature Ovarian Failure: An Experimental Study
Prematür Overyan Yetmezlikli Ratlarda Yaş Kupa Terapisinin Anksiyete ve Tiyol/Disülfit Homeostazı Üzerine Etkileri: Deneysel Bir Çalışma
Hümeyra ÇELİKa, Ayhan ÇETİNKAYAa, Bihter Gökçe BOZATb, Selma ERDOĞAN DÜZCÜc, Murat ALIŞIKd, Özgür Mehmet YİSd
aDepartment of Physiology, Bolu Abant İzzet Baysal University Faculty of Medicine, Bolu, Türkiye
bDepartment of Interdisciplinary Neuroscience, Bolu Abant İzzet Baysal University Health Science Institute, Bolu, Türkiye
cDepartment of Pathology, Bolu Abant İzzet Baysal University Faculty of Medicine, Bolu, Türkiye
dDepartment of Biochemistry, Bolu Abant İzzet Baysal University Faculty of Medicine, Bolu, Türkiye
J Tradit Complem Med. 2022;5(1):12-21
doi: 10.5336/jtracom.2021-83703
Article Language: EN
Full Text
ABSTRACT
 Objective: The effect of wet cupping therapy on anxiety and thiol/disulfide homeostasis was evaluated in rats with premature ovarian failure (POF) induced by cyclophosphamide (CYC). Material and Methods: Twenty four Wistar Albino female rats were divided into control (n=6), POF (n=6), wet cupping (n=6), POF+wet cupping (n=6) groups. CYC at a dose of 200 mg/kg was injected intraperitoneally to POF and POF+wet cupping groups. One week later, wet cupping therapy was applied to wet cupping and POF+wet cupping groups for 5 minutes. The next day, Open Field Test and Elevated Plus Maze Test were applied to all experimental groups to evaluate anxiety. After sacrification, to assess pattern formation, endometrial thickness and ovarian reserve were measured with hematoxylin-eosin staining. Thiol/disulfide homeostasis and erythrocyte oxidized-reduced glutathione levels were measured in serum to measure oxidative stress. Results: Although there was no statistical significance, it was observed that anxiety decreased in POF+wet cupping compared to POF group. There was no change in thiol-disulfide values in POF+wet cupping compared to POF group (p>0.05). Conclusion: Wet cupping therapy did not reduce anxiety in the experimental POF model and did not shift the balance to positive in thiol/disulfide homeostasis in favor of thiols. However, the obtained graphics, numerical data and high standard deviation suggest that meaningful data could be obtained with more subjects.

Keywords: Cupping theraphy; cyclophosphamide; premature ovarian failure; anxiety; sulfydryl compounds
ÖZET
 Amaç: Siklofosfamid [cyclophosphamide (CYC)] ile indüklenmiş prematür overyan yetmezliği (POF) olan ratlarda yaş kupa terapisinin anksiyete ve tiyol/disülfid homeostazı üzerindeki etkileri değerlendirildi. Gereç ve Yöntemler: Yirmi dört adet Wistar Albino dişi rat kontrol (n=6), POF (n=6), yaş kupa (n=6), POF+yaş kupa (n=6) gruplarına ayrıldı. POF ve POF+yaş kupa gruplarına 200 mg/kg CYC intraperitoneal olarak enjekte edildi. Bir hafta sonra yaş kupa ve POF+yaş kupa gruplarına 5 dk süreyle kupa terapisi uygulandı. Ertesi gün, anksiyeteyi değerlendirmek için tüm deney gruplarına Açık Alan Testi ve Yükseltilmiş Artı Labirent Testi uygulandı. Sakrifikasyonun ardından model oluşumunu değerlendirmek için endometrial kalınlık ve over rezervi hematoksilen-eozin boyası ile ölçüldü. Oksidatif stresi değerlendirmek amacıyla toplanan serumlardan tiyol/disülpid homeostazı ve eritrosit okside-redükte glutatyon düzeyleri bakıldı. Bulgular: İstatistiksel olarak anlamlı olmamakla birlikte POF+yaş kupa grubunda POF grubuna göre anksiyetenin azaldığı görüldü. Tiyol-disülfid değerlerinde ise POF+yaş kupa grubunda POF grubuna göre bir farklılık bulunmadı (p>0,05). Sonuç: Yaş kupa terapisinin deneysel POF modelinde anksiyeteyi azaltmadığı ve tiyol/disulfit homeostazında dengeyi tiyoller yönünden pozitif balansa kaydırmadığı gözlemlenmiştir. Ancak elde edilen grafikler, sayısal veriler ve standart sapmanın yüksek oluşu daha fazla denek ile anlamlı sonuçların elde edilebileceğini düşündürmektedir.

Anahtar Kelimeler: Kupa terapisi; siklofosfamid; prematür ovaryan yetmezlik; anksiyete; sülfidril bileşikleri
REFERENCES:
  1. Kuang H, Han D, Xie J, Yan Y, Li J, Ge P. Profiling of differentially expressed microRNAs in premature ovarian failure in an animal model. Gynecol Endocrinol. 2014;30(1):57-61. [Crossref]  [PubMed] 
  2. Kodaman PH. Early menopause: primary ovarian insufficiency and surgical menopause. Semin Reprod Med. 2010;28(5):360-9. [Crossref]  [PubMed] 
  3. Stotland N. Psychiatric consultation to obstetrics and gynecology. Psychological Aspects of Women's Health Care. 1993.
  4. Edey KA, Rundle S, Hickey M. Hormone replacement therapy for women previously treated for endometrial cancer. Cochrane Database Syst Rev. 2018;5(5):CD008830. [Crossref]  [PubMed]  [PMC] 
  5. Gold EB, Sternfeld B, Kelsey JL, Brown C, Mouton C, Reame N, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152(5):463-73. [Crossref]  [PubMed] 
  6. Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, et al; European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-37. [Crossref]  [PubMed] 
  7. Thase ME, Shelton RC, Khan A. Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard-and higher-dosing strategies. J Clin Psychopharmacol. 2006;26(3):250-8. [Crossref]  [PubMed] 
  8. Hollifield M, Sinclair-Lian N, Warner TD, Hammerschlag R. Acupuncture for posttraumatic stress disorder: a randomized controlled pilot trial. J Nerv Ment Dis. 2007;195(6):504-13. [Crossref]  [PubMed] 
  9. Avis NE, Coeytaux RR, Isom S, Prevette K, Morgan T. Acupuncture in Menopause (AIM) study: a pragmatic, randomized controlled trial. Menopause. 2016;23(6):626-37. [Crossref]  [PubMed]  [PMC] 
  10. Chirali IZ. Cupping Therapy. Philadelphia, PA: Elservier; 2007. eBook ISBN: 9780702058349, Paperback ISBN: 9780702043529, [Link] 
  11. Christopoulou-Aletra H, Papavramidou N. Cupping: an alternative surgical procedure used by Hippocratic physicians. J Altern Complement Med. 2008;14(8):899-902. [Crossref]  [PubMed] 
  12. Iqubal A, Sharma S, Najmi AK, Syed MA, Ali J, Alam MM, et al. Nerolidol ameliorates cyclophosphamide-induced oxidative stress, neuroinflammation and cognitive dysfunction: plausible role of Nrf2 and NF- κB. Life Sci. 2019;236:116867. [Crossref]  [PubMed] 
  13. Oh JY, Kim YK, Kim SN, Lee B, Jang JH, Kwon S, et al. Acupuncture modulates stress response by the mTOR signaling pathway in a rat post-traumatic stress disorder model. Scientific Reports. 2018;8(1):11864. [Crossref]  [PubMed]  [PMC] 
  14. Smith BJ, Plowchalk DR, Sipes IG, Mattison DR. Comparison of random and serial sections in assessment of ovarian toxicity. Reprod Toxicol. 1991;5(4):379-83. [Crossref]  [PubMed] 
  15. Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-32. [Crossref]  [PubMed] 
  16. Alisik M, Neselioglu S, Erel O. A colorimetric method to measure oxidized, reduced and total glutathione levels in erythrocytes. Journal of Laboratory Medicine. 2019;43(5):269-77. [Crossref] 
  17. Vural B, Duruksu G, Vural F, Gorguc M, Karaoz E. Effects of VEGF+mesenchymal stem cells and platelet-rich plasma on inbred rat ovarian functions in cyclophosphamide-induced premature ovarian insufficiency model. Stem Cell Rev Rep. 2019;15(4):558-73. [Crossref]  [PubMed] 
  18. Al-Bedah AMN, Elsubai IS, Qureshi NA, Aboushanab TS, Ali GIM, El-Olemy AT, et al. The medical perspective of cupping therapy: effects and mechanisms of action. J Tradit Complement Med. 2018;9(2):90-7. [Crossref]  [PubMed]  [PMC] 
  19. Subadi I, Nugraha B, Laswati H, Josomuljono H. Pain relief with wet cupping therapy in rats is mediated by heat shock protein 70 and ß-endorphin. Iran J Med Sci. 2017;42(4):384-91. [PubMed]  [PMC] 
  20. Chen Y, Fang Y, Yang J, Wang F, Wang Y, Yang L. Effect of acupuncture on premature ovarian failure: a pilot study. Evid Based Complement Alternat Med. 2014;2014:718675. [Crossref]  [PubMed]  [PMC] 
  21. Melekoglu R, Ciftci O, Eraslan S, Cetin A, Basak N. Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model. J Ovarian Res. 2018;11(1):33. [Crossref]  [PubMed]  [PMC] 
  22. Torrealday S, Kodaman P, Pal L. Premature ovarian insufficiency-an update on recent advances in understanding and management. F1000Res. 2017;6:2069. [Crossref]  [PubMed]  [PMC] 
  23. Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol. 2008;26(5):753-8. [Crossref]  [PubMed] 
  24. Wang SM, Kain ZN, White P. Acupuncture analgesia: I. the scientific basis. Anesth Analg. 2008;106(2):602-10. [Crossref]  [PubMed] 
  25. Ahmedi M, Siddiqui MR. The value of wet cupping as a therapy in modern medicine‐an Islamic perspective. Webmed Central Alternative Medicine. 2014;5(12):WMC004785. [Link] 
  26. Sniezek DP, Siddiqui IJ. Acupuncture for treating anxiety and depression in women: a clinical systematic review. Med Acupunct. 2013;25(3):164-72. [Crossref]  [PubMed]  [PMC] 
  27. Tagil SM, Celik HT, Ciftci S, Kazanci FH, Arslan M, Erdamar N, et al. Wet-cupping removes oxidants and decreases oxidative stress. Complement Ther Med. 2014;22(6):1032-6. [Crossref]  [PubMed] 
  28. Wu SL, Leung AW, Yew DT. Acupuncture for detoxification in treatment of opioid addiction. East Asian Arch Psychiatry. 2016;26(2):70-6. [PubMed] 
  29. Bodnar RJ. Endogenous opiates and behavior: 2017. Peptides. 2020;124:170223. [Crossref]  [PubMed] 
  30. Gao LW. Practical Cupping Therapy [in Chinese]. Beijing: Academy Press; 2004.
  31. Flanigan TJ, Anderson JE, Elayan I, Allen AR, Ferguson SA. Effects of cyclophosphamide and/or doxorubicin in a murine model of postchemotherapy cognitive ımpairment. Toxicol Sci. 2018;162(2):462-74. [Crossref]  [PubMed]  [PMC] 
  32. Spears N, Lopes F, Stefansdottir A, Rossi V, De Felici M, Anderson RA, et al. Ovarian damage from chemotherapy and current approaches to its protection. Hum Reprod Update. 2019;25(6):673-93. [Crossref]  [PubMed]  [PMC] 
  33. Sharma SK, Jain S, Bahl P, Potturi P, Rathi M, Naidu S, et al. Ovarian dysfunction with moderate-dose intravenous cyclophosphamide (modified NIH regimen) and mycophenolate mofetil in young adults with severe lupus: a prospective cohort study. Arthritis Res Ther. 2020;22(1):189. [Crossref]  [PubMed]  [PMC] 
  34. Kirshner ZZ, Yao JK, Li J, Long T, Nelson D, Gibbs RB. Impact of estrogen receptor agonists and model of menopause on enzymes involved in brain metabolism, acetyl-CoA production and cholinergic function. Life Sci. 2020;256:117975. [Crossref]  [PubMed]  [PMC] 
  35. Lagunas N, Calmarza-Font I, Diz-Chaves Y, Garcia-Segura LM. Long-term ovariectomy enhances anxiety and depressive-like behaviors in mice submitted to chronic unpredictable stress. Horm Behav. 2010;58(5):786-91. [Crossref]  [PubMed] 

.: Up To Date

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com